argenx SE (ARGX)

286.54 -6.62  -2.26% NASDAQ Oct 25, 16:00 287.14 +0.60  +0.21% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All ARGX News

News

View All Events

Events

Date Type Description
10/28/2021 Earnings Results Q3 2021 Earnings Results
10/28/2021 Earnings Calls Q3 2021 Earnings Call
07/29/2021 Earnings Results Q2 2021 Earnings Results
07/29/2021 Earnings Calls Q2 2021 Earnings Call
05/14/2021 Earnings Results Q1 2021 Earnings Results
05/14/2021 08:30 EST Earnings Calls Q1 2021 Earnings Call
05/11/2021 AGM 2020 Annual General Meeting
03/04/2021 Earnings Results Q4 2020 Earnings Results
03/04/2021 08:30 EST Earnings Calls Q4 2020 Earnings Call
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: argenx SE is a clinical stage biotechnology company. It is engaged in the business of developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. Its product pipeline includes product candidates such as ARGX-111, ARGX-109, ARGX-115, ARGX-112, and others. The company operates in the Netherlands, Germany, Denmark, Belgium, Switzerland, the United States, and Luxembourg. It derives the majority of its revenues from Switzerland.
  • URL: http://www.argenx.com
  • Investor Relations URL: https://www.argenx.com/investors
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Oct. 28, 2021
  • Last Earnings Release: Jul. 29, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
CNCR Loncar Cancer Immunotherapy ETF 3.41%
ARTSX Artisan Small Cap Investor 2.77%
FACTX Fidelity Advisor® Health Care M 2.24%
FSPHX Fidelity® Select Health Care 2.06%
APDMX Artisan Mid Cap Advisor 1.77%
FBIOX Fidelity® Select Biotechnology 1.67%
BMED BlackRock Future Health ETF 1.35%
HQL Tekla Life Sciences Investors 1.31%
THISX T. Rowe Price Health Sciences I 1.29%
BMEZ BlackRock Health Sciences Trust II 1.03%
HQH Tekla Healthcare Investors 0.95%
IBB iShares Biotechnology ETF 0.83%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.